2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Metastatic Squamous Neck Cancer
Metastatic squamous neck cancer refers to cancer that originates in the squamous cells of the head and neck region and has spread to lymph nodes or distant organs. Research in this area focuses on improving treatment outcomes and understanding the molecular mechanisms driving metastasis. Scientists explore novel therapies such as immunotherapy, targeted therapy, and combination treatments to combat metastatic spread. Additionally, advancements in diagnostic techniques like genomic profiling aid in personalized treatment approaches, tailoring therapy to the individual patient's tumor characteristics. Early detection strategies and supportive care interventions also play crucial roles in managing metastatic squamous neck cancer, aiming to enhance patient quality of life and survival rates. By integrating multidisciplinary approaches, researchers strive to address the complexities of metastatic disease and improve patient outcomes.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Northeastern University, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Rihab Melliti
Aix en Provence General Hospital, FranceSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Nanomedicine in humans: 30 years of fighting diseases
Thomas J Webster, Northeastern University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation